A simulation model to calculate costs and benefits of dry period interventions in dairy cattle

Livestock Science

Volumn 129, Issue 1-3, 2010, Pages 80-87

  Halasa, T ^a,b   Nielen, M ^a   van Werven, T ^a   Hogeveen, H ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Dry cow therapy; Economic model; Mastitis; Teat sealant

Indexed keywords

BOS; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS;

EID: 77649271001     PISSN: 18711413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.livsci.2010.01.009     Document Type: Article

References (30)

1. Becker N.G. Analysis of Infectious Disease Data (1989), Chapman and Hall, London, UK
2. Berry E.A., and Hillerton J.E. Effect of an intramammary teat seal and dry cow antibiotic in relation to dry period length on postpartum mastitis. J. Dairy Sci. 90 (2007) 760-765
3. Berry E.A., Hogeveen H., and Hillerton J.E. Decision tree analysis to evaluate dry cow strategies under UK conditions. J. Dairy Res. 71 (2004) 409-418
4. Bradley A.J., and Green M.J. The importance of the nonlactating period in the epidemiology of intramammary infection and strategies for prevention. Vet. Clin. North Am. Food Anim. Pract. 20 (2004) 547-568
5. Dingwell R.T., Leslie K.E., Duffield T.F., Schukken Y.H., Des Coteaux L., Keefe G.P., Kelton D.F., Lissemore K.D., Shwefelt W., Dick P., and Bagg R. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J. Dairy Sci. 86 (2003) 159-168
6. Dodd F.H., Westgarth D.R., Neave F.K., and Kingwell R.G. Mastitis - the strategy of control. J. Dairy Sci. 52 (1969) 689-695
7. Eberhart R.J. Management of dry cows to reduce mastitis. J. Dairy Sci. 69 (1986) 1721-1732
8. Godden S., Rapnicki P., Stewart S., Fetrow J., Johnson A., Bey R., and Farnsworth R. Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J. Dairy Sci. 86 (2003) 3899-3911
9. Green M.J., Green L.E., Medley G.F., Schukken Y.H., and Bradley A.J. Influence of dry period bacterial intramammary infection on clinical mastitis in dairy cow. J. Diary Sci. 85 (2002) 2589-2599
10. Green M.J., Green L.E., Bradley A.J., Burton P.R., Schukken Y.H., and Medley G.F. Prevalence and associations between bacterial isolates from dry mammary glands of dairy cows. Vet. Rec. 156 (2005) 71-77
11. Green M.J., Bradley A.J., Medley G.F., and Browne W.J. Cow, farm, and management factors during the dry period that determine the rate of clinical mastitis after calving. J. Dairy Sci. 90 (2007) 3764-3776
12. Halasa T., Huijps K., Østerås O., and Hogeveen H. Economic effects of bovine mastitis and mastitis management: a review. Vet. Q. 29 (2007) 18-31
13. Halasa T., Østerås O., van Werven T., Hogeveen H., and Nielen M. Meta-analysis on dry cow management for dairy cattle. Part 1: protection against new intramammary infections. J. Dairy Sci 92 (2009) 3134-3149
14. Halasa T., Nielen M., Whist A.C., and Østerås O. Meta-analysis on dry cow management for dairy cattle. Part 2: cure of existing intramammary infections. J. Dairy Sci 92 (2009) 3150-3157
15. Halasa T., Nielen M., Huirne R.B.M., and Hogeveen H. Stochastic bio-economic model of bovine intramammary infection. Livest. Sci. 124 (2009) 295-305
16. Huijps K., and Hogeveen H. Economic evaluation of dry cow therapy. J. Dairy Sci. 90 (2007) 1225-1234
17. Huxley J.N., Green M.J., Green L.E., and Bradley A.J. Evaluation of the efficacy of an internal teat sealer during the dry period. J. Dairy Sci. 85 (2002) 551-561
18. McNab B.W., and Meek A.H. A benefit cost analysis of dry-cow mastitis therapy in dairy cattle in Ontario. Can. Vet. J. 32 (1991) 347-353
19. Newton H.T., Green M.J., Benchaoui H., Cracknell V., Rowan T., and Bradley A.J. Comparison of the efficacy of cloxacillin alone and cloxacillin combined with an internal teat sealant for dry-cow therapy. Vet. Rec. 162 (2008) 678-684
20. NRS. Annual Statistics (2005) (2005), CR-Delta, Arnhem, The Netherlands
21. Oliver S.P., Lewis M.J., Gillespie B.E., Dowlen H.H., Jaenicke E.C., and Roberts R.K. Prepartum antibiotic treatment of heifers: milk production, milk quality and economic benefit. J. Dairy Sci. 86 (2003) 1187-1193
22. Østerås O., Aursjo J., Gronningsaeter Gjul G., and Jorstad A. Effect of dry-cow therapy on subclinical mastitis - an evaluation of long acting and short acting intramammaria. J. Vet. Med. B 41 (1994) 529-540
23. Østergaard S., Chagunda M.G.G., Friggens N.C., Bennedsgaard T.W., and Klaas I.C. A stochastic model simulating pathogen-specific mastitis control in a dairy herd. J. Dairy Sci. 88 (2005) 4243-4257
24. Parker K.I., Compton C., Anniss F.M., Heuer C., and McDougall S. Quarter-level analysis of subclinical and clinical mastitis in primiparous heifers following the use of a teat sealant or an injectable antibiotic, or both, precalving. Dairy Sci. 91 (2008) 169-181
25. Schukken Y.H., van Vliet J., van de Geer D., and Grommer F.J. A randomized blind trial on dry cow antibiotic infusion in a low somatic cell count herd. J. Dairy Sci. 76 (1993) 2925-2930
26. Whist A.C., and Østerås O. Associations between somatic cell counts at calving or prior to drying-off and clinical mastitis in the remaining or subsequent lactation. J. Dairy Res. 74 (2007) 66-73
27. Wolfram Research Europe Ltd. Blenheim Office Park (2007), Long Hanborough, Oxfordshire, UK
28. Woolford M.W., Williamson J.H., Day T.M., Lacy-Hulbert S.J., and Handerson H.V. Effect of localised antibiotic infusions applied to the teat-canal and teat sinus at drying-off on mastitis in the dry-period and at calving. J. Dairy Res. 68 (2001) 551-558
29. Zadoks R.N., Allore H.G., Barkema H.W., Sampimon O.C., Grohn Y.T., and Schukken Y.H. Analysis of an outbreak of Streptococcus uberis mastitis. J. Dairy Sci. 84 (2001) 590-599
30. Zadoks R.N., Allore H.G., Hagenaars T.J., Barkema H.W., and Schukken Y.H. A mathematical model of Staphylococcus aureus control in dairy herds. Epidemiol. Infect. 129 (2002) 397-416